Mr. Navchand Jagpal
Acting CEO, CFO & Director
Biography unavailable
A
Albert Labs International Corp
F:VB50
Albert Labs International Corp
F:VB50
Price:
0.005
EUR
Market Closed
Market Cap:
€372.1k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Albert Labs International Corp
F:VB50
|
CA |
Company Overview
Business Description
- Headquarters
- Canada CA
- IPO date
- Apr 29, 2010
Albert Labs International Corp. operates as a research and drug development company. The company is headquartered in Surrey, British Columbia. The company went IPO on 2010-04-29. The firm is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The firm focuses on treating patients with urgent and unmet mental health needs, starting with cancer-related anxiety. The company is also focused on improving patient access to psychedelic-assisted therapies. The firm has an asset-light business model, leveraging existing clinical infrastructure and patient pools by collaborating with research institutions, medical centers and reimbursement networks. The firm uses an accelerated pathway, Real-World Evidence (RWE) studies, to provide access to patients in need. The firm also provides in-house lab results in formulation.
Continue VB50 Research
Other Albert Labs International Corp listings: